Overview

Relative Bioavailability Study of Four Experimental Formulations for Alzheimer's Disease

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the bioavailability of four experimental formulations relative to the current reference formulation used in the Phase 2 study.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb